A_DT
novel_JJ
HIV-1_NN
isolate_NN
containing_VBG
alterations_NNS
affecting_VBG
the_DT
NF-kappa_NN
B_NN
element_NN
._.

Three_CD
molecular_JJ
clones_NNS
of_IN
HIV-1_NN
,_,
derived_VBN
from_IN
a_DT
single_JJ
isolate_NN
-LRB-_-LRB-
AL1_NN
-RRB-_-RRB-
,_,
exhibited_VBD
distinct_JJ
replicative_JJ
and_CC
cytopathic_JJ
properties_NNS
during_IN
propagation_NN
in_IN
a_DT
human_JJ
T_NN
cell_NN
line_NN
._.

The_DT
phenotypic_JJ
differences_NNS
observed_VBN
were_VBD
attributable_JJ
,_,
in_IN
large_JJ
part_NN
,_,
to_TO
changes_NNS
affecting_VBG
the_DT
viral_JJ
LTR_NN
._.

Nucleotide_NN
sequence_NN
and_CC
PCR_NN
analyses_NNS
demonstrated_VBD
the_DT
presence_NN
of_IN
novel_JJ
duplications_NNS
or_CC
deletions_NNS
involving_VBG
the_DT
NF-kappa_NN
B_NN
motif_NN
._.

These_DT
changes_NNS
in_IN
the_DT
enhancer_NN
element_NN
were_VBD
identified_VBN
in_IN
the_DT
original_JJ
AL1_NN
virus_NN
stock_NN
._.

Subcloning_NN
of_IN
the_DT
variant_JJ
NF-kappa_NN
B_NN
segments_NNS
into_IN
LTR-driven_JJ
CAT_NN
expression_NN
vectors_NNS
confirmed_VBD
a_DT
correlation_NN
between_IN
promoter_NN
activity_NN
and_CC
replicative\/cytopathic_JJ
capacity_NN
._.

